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Summary: In this paper, we study the problem of testing the mean vectors of high dimensional data in both one-
sample and two-sample cases. The proposed testing procedures employ maximum-type statistics and the parametric
bootstrap techniques to compute the critical values. Different from the existing tests that heavily rely on the structural
conditions on the unknown covariance matrices, the proposed tests allow general covariance structures of the data
and therefore enjoy wide scope of applicability in practice. To enhance powers of the tests against sparse alternatives,
we further propose two-step procedures with a preliminary feature screening step. Theoretical properties of the
proposed tests are investigated. Through extensive numerical experiments on synthetic datasets and an human acute
lymphoblastic leukemia gene expression dataset, we illustrate the performance of the new tests and how they may
provide assistance on detecting disease-associated gene-sets. The proposed methods have been implemented in an
R-package HDtest and are available on CRAN.
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1. Introduction
The problems of comparing a particular sample to a hypothetical population with known
prior information or comparing two parallel groups, such as a control group and a treatment
group, have both important applications in modern genomics and bio-medical research and
become the foundation of scientific discoveries. They have been employed widely for identi-
fying biologically interesting gene-sets for drug design, evolutionary studies, and mutation
detection. Our interests in these problems are motivated by a microarray study on human
acute lymphoblastic leukemia (Chiaretti et al., 2004). This study consists of 75 patients of B-
lymphocyte type leukemia, who were classified into two groups: 35 patients with BCR/ABL
fusion and 40 patients with cytogenetically normal NEG. It is known that genes tend to work
collectively in groups to achieve certain biological tasks. Our analysis focuses on such groups
of genes (gene sets) defined with the gene ontology (GO) framework, which are referred to
as GO terms. Identifying disease-relevant GO terms based on their average expression levels
provides information on differential gene pathways associated with the leukemia. Many GO
terms contain a large number of (in the data, as many as 3,145) genes with very complex
gene-wise dependence structures. The large dimension of data and the complex dependency
among genes make the problem of comparing population means extremely challenging.
Let X and Y be two p-dimensional random vectors with means µ1 = (µ11, . . . , µ1p)
T
and µ2 = (µ21, . . . , µ2p)
T, covariance matrices Σ1 = (σ1,k`)16k,`6p and Σ2 = (σ2,k`)16k,`6p,
respectively. It is then of general interest in testing the hypotheses
• (One-sample problem) H (I)0 : µ1 = µ0 versus H (I)1 : µ1 6= µ0 for a specified p-dimensional
vector µ0, which, without loss of generality, is equivalent to
H (I)0 : µ1 = 0 versus H
(I)
1 : µ1 6= 0; (1.1)
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• (Two-sample problem)
H (II)0 : µ1 = µ2 versus H
(II)
1 : µ1 6= µ2. (1.2)
When p is fixed, traditional tests have been extensively studied for testing both (1.1) and
(1.2). For example, the properties for both the one-sample and two-sample Hotelling’s T 2
tests have been examined under normality assumption (Anderson, 2003). We refer to Liu
and Shao (2013) for a moderate deviation result in the absence of normality.
Generally, the sum of squares-type and the maximum-type statistics are used to test the
hypotheses (1.1) and (1.2) in the high dimensional settings. The sum of squares-type statistics
aim to mimic the weighted Euclidean norms, |Aµ1|22 or |A(µ1 − µ2)|22 for certain linear
transformation A, and the corresponding tests are powerful for detecting relatively dense
signals (Bai and Saranadasa, 1996; Chen and Qin, 2010). Statistics of the maximum-type,
on the other hand, are preferable for detecting relatively sparse signals (Cai et al., 2014) and
have been used in a variety of applications including the medical image problem (James et
al., 2001) and gene selections (Martens et al., 2005).
Most existing testing procedures for (1.1) and (1.2) rely on the derivation the pivotal lim-
iting distribution of test statistics, from which the critical value is approximated. In the high
dimensional scenarios, various structural assumptions on the unknown covariance matrices
have been imposed (Zhong et al., 2013; Cai et al., 2014). However, in many applications,
these assumptions can be very restrictive or difficult to be verified, and therefore limit the
scope of applicability for the limiting distribution calibration approach. First, the existence
of a pivotal asymptotic distribution relies heavily on the structural assumptions on the
unknown covariance/correlation structures, which may not be true in practice. For example,
it is very common that the expression levels are highly correlated for genes regulated by the
same pathway (Wolen and Miles, 2012) or associated with the same functionality (Katsani et
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al., 2014), which results in a complex and non-sparse covariance structure. These empirical
evidences indicate that the strong structural assumptions on the covariance matrices may
sometimes be unrealistic in real-world applications. Another concern, as pointed out by Cai
et al. (2014), is that the convergence rate to the extreme value distribution of maximum-
type statistics is usually slow. Taking the extreme distribution of type I as an example,
the convergence rate is of order O{log(log n)/ log(n)}. Although the convergence rate may
be improved by using suitable intermediate approximations, still its validity relies on the
dependence structure of the underlying distribution.
Driven by the above two concerns, we revisit the problem of testing hypotheses (1.1)
and (1.2) from a different perspective. Motivated by applications in genomic analysis and
image analysis, we are particularly interested in detecting discrepancies when µ1 and 0 or
µ2 are distinguishable to a certain extent in at least one coordinate. We develop a fully
data driven procedure to compute the critical values using the Monte Carlo simulations.
The validity of our procedure is established without enforcing structural assumptions of
any kind on the unknown covariances. The main idea is based on the approximation of
empirical processes by Gaussian processes (Chernozhukov et al., 2013), and to some degree, is
similar to that of Liu and Shao (2013) that utilizes the intermediate approximation. However,
instead of generating independent standard multivariate normal vectors, our approach takes
into account correlations among the features and therefore is automatically adapted to the
underlying dependence.
The rest of the paper is organized as follows. In Section 2, we describe the simulation-based
testing procedures for both hypotheses (1.1) and (1.2). Theoretical properties of the tests are
studied in Section 3. Numerical studies are reported in Section 4 to assess the performance
of the proposed tests comparing to the peer methods. In Section 5, we applied the proposed
tests to the acute lymphoblastic leukemia data for identifying disease-associated gene-sets
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based on the gene expression levels. The underpinning technical details, as well as additional
simulation results and empirical data analysis, are relegated to the supplementary material.
2. Methodology
Throughout the paper, we denote by |β|∞ = max16k6p |βk| for a p-dimensional vector β =
(β1, . . . , βp)
T. For a matrix A = (ak`)p×p, define |A|∞ = max16k,`6p |ak`|. Let D1 = diag (Σ1)
and D2 = diag (Σ2). Denote by R1 and R2 the corresponding correlation matrices. Let
Xn = {X1, . . . ,Xn} and Ym = {Y1, . . . ,Ym} be two independent samples consisting of
independent and identically distributed (i.i.d.) observations drawn from the distributions
of X and Y, respectively. Let N = n + m. For each i = 1, . . . , n and j = 1, . . . ,m, write
Xi = (Xi1, . . . , Xip)
T and Yj = (Yj1, . . . , Yjp)
T.
2.1 Test procedures
2.1.1 One-sample case. Consider the maximum-type statistics in the following forms:
T (I)ns = max
16k6p
√
n|X¯k| or T (I)s = max
16k6p
√
n|X¯k|
σˆ1k
, (2.1)
where X¯k = n
−1∑n
i=1Xik and σˆ
2
1k = n
−1∑n
i=1(Xik − X¯k)2. Throughout, the statistic T (I)s
is referred as the studentized statistic, while T (II)ns is referred as the non-studentized statistic.
Intuitively, large values of T (I)ns or T
(I)
s provide evidences against H
(I)
0 in (1.1) so that the
corresponding tests are of the form Ψ(I)ns,α = I{T (I)ns > cv(I)ns,α} or Ψ(I)s,α = I{T (I)s > cv(I)s,α}, where
cv(I)ns,α and cv
(I)
s,α are the critical values.
Under the null hypothesis H (I)0 : µ1 = 0, we motivate from the multivariate central limit
theorem with fixed p to calculate critical values cv(I)ns,α and cv
(I)
s,α as follows: let Σ˜1 be an
estimate of Σ1 from the sample Xn, and set R˜1 = D˜−1/21 Σ˜1D˜−1/21 with D˜1 = diag (Σ˜1).
Given Xn, let W(I)ns ∼ N(0, Σ˜1) and W(I)s ∼ N(0, R˜1) be two Gaussian random vectors, the
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critical values can be computed by cv(I)ns,α = inf{t ∈ R : P(|W(I)ns |∞ > t |Xn) 6 α} and
cv(I)s,α = inf{t ∈ R : P(|W(I)s |∞ > t |Xn) 6 α}. Practically, let {Wns,`}M`=1 i.i.d.∼ N(0, Σ˜1)
and {Ws,`}M`=1 i.i.d.∼ N(0, R˜1). Then, cv(I)ns,α and cv(I)s,α can be estimated by ĉv (I)ns,α = inf{t ∈
R : F̂ (I)ns,M(t) > 1 − α} and ĉv (I)s,α = inf{t ∈ R : F̂ (I)s,M(t) > 1 − α}, where F̂ (I)ns,M(t) =
M−1
∑M
`=1 I{|Wns,`|∞ 6 t} and F̂ (I)s,M(t) = M−1
∑M
`=1 I{|Ws,`|∞ 6 t}. For ν ∈ {ns, s}, the
empirical version of test Ψ(I)ν,α is therefore defined by
Ψ̂(I)ν,α(M) = I{T (I)ν > ĉv (I)ν,α}, (2.2)
such that the null hypothesis H (I)0 is rejected whenever Ψ̂
(I)
ν,α(M) = 1. The proposed test-
ing procedures are fully data driven and easily computed. In Section 2.2, we discuss the
constructions of Σ˜1, from which the wide applicability of the test (2.2) will be explored.
2.1.2 Two-sample case. The above procedures can be naturally extended to deal with the
two-sample problem (1.2). Analogously to (2.1), we define the non-studentized and studen-
tized test statistics by T (II)ns = max16k6p
√
nm|X¯k−Y¯k|/
√
n+m and T (II)s = max16k6p
√
nm|X¯k−
Y¯k|/(mσˆ21k + nσˆ22k)1/2 respectively, where X¯k = n−1
∑n
i=1Xik, Y¯k = m
−1∑m
j=1 Yjk, σˆ
2
1k =
n−1
∑n
i=1(Xik − X¯k)2, and σˆ22k = m−1
∑m
j=1(Yjk − Y¯k)2. For nominal significance level α, we
define tests of the form Ψ(II)ns,α = I{T (II)ns > cv(II)ns,α} or Ψ(II)s,α = I{T (II)s > cv(II)s,α} with appropriate
critical values cv(II)ns,α and cv
(II)
s,α. Let Σ˜1 and Σ˜2 be estimates of Σ1 and Σ2, respectively. Define
Σ˜1,2 =
m
N
Σ˜1 +
n
N
Σ˜2, D˜1,2 = diag
(
Σ˜1,2
)
, R˜1,2 = D˜
−1/2
1,2 Σ˜1,2D˜
−1/2
1,2 , (2.3)
and let {Wns,`}M`=1 i.i.d.∼ N(0, Σ˜1,2) and {Ws,`}M`=1 i.i.d.∼ N(0, R˜1,2). Then, cv(II)ns,α and cv(II)s,α can be
estimated by ĉv (II)ns,α = inf{t ∈ R : F̂ (II)ns,M(t) > 1−α} and ĉv (II)s,α = inf{t ∈ R : F̂ (II)s,M(t) > 1−α},
where F̂ (II)ns,M(t) = M
−1∑M
`=1 I{|Wns,`|∞ 6 t} and F̂ (II)s,M(t) = M−1
∑M
`=1 I{|Ws,`|∞ 6 t}.
Similarly to (2.2), for ν ∈ {ns, s}, we define the empirical version of Ψ(II)ν,α by Ψ̂(II)ν,α(M) =
I{T (II)ν > ĉv (II)ν,α}, such that the null hypothesis H (II)0 is rejected as long as Ψ̂(II)ν,α(M) = 1.
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2.2 Estimation of covariance matrices
As a part of proposed tests, we need estimates of the covariance matrices. Many existing tests
rely on the operator-norm consistent estimation of the covariance matrices that requires extra
structural assumptions on the unknown covariances such as banding or sparsity. In contrast,
the proposed tests require much less restrictions on covariance estimates, which grants its
wide scope of applicability. In fact, the validity of the proposed testing procedures only entails
the covariance estimators Σ˜1 and Σ˜2 to satisfy |Σ˜1−Σ1|∞ = oP (1) and |Σ˜2−Σ2|∞ = oP (1).
It is shown in Lemma 3 in the supplementary material that for the sample covariance
and correlation matrices Σ̂q and R̂q with q = 1, 2, there holds |Σ̂q −Σq|∞ + |R̂q −Rq|∞ =
oP (1) under mild regularity conditions for log(p) = o(n
γ/2) with 0 < γ 6 2. Therefore,
the sample covariance and correlation matrices can be directly used in the proposed tests,
while the dimension p is allowed to be as large as either O{exp(nc1)} for some c1 > 0.
In comparison to the existing tests, we do not enforce any structural assumptions on the
unknown covariance matrices Σ1 and Σ2. This reflects our motivations in Section 1. As
evidenced by extensive numerical studies in Section 4, our proposed procedures are fairly
robust to various covariance structures with complex forms, even the long range dependence.
Although the proposed tests do not require operator-norm consistent estimates of Σ1 and Σ2,
still one may replace the sample covariance matrix by adaptive and rate-optimal covariance
estimators to improve the empirical performance when the underlying covariance satisfies
certain structural assumptions.
2.3 Screening-based testing procedures
The proposed testing procedures are valid when the dimension p is much larger than the
sample size n. However, building tests based on all dimensions may result in large critical
values which may compromise the power performance. To enhance the power, we propose
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a two-step procedure that combines the proposed simulation-based tests and a preliminary
step on feature screening, which screens the p measurements before conducting the test. The
power of this two-step procedure is expected to improve upon the proposed tests with a large
number of irrelevant features excluded.
2.3.1 One-sample case. Let S10 = {1 6 k 6 p : µ1k = 0}. The preliminary procedure
is aimed at eliminating irrelevant features indexed by S10. Reformulate the original global
test of a mean vector to the following p marginal tests: H (I)0k : µ1k = 0 versus H
(I)
1k : µ1k 6= 0,
for k = 1, . . . , p. For the kth marginal hypothesis, a standard test statistic is the t-statistic
TS(I)k =
√
n|X¯k|/σˆ1k. Motivated by the idea of marginal screening (Chang et al., 2013, 2016),
we define the index set Ŝ1 = {1 6 k 6 p : TS(I)k 6
√
2 log(p)+{2 log(p)}−1/2 +√2 log(1/α)}.
We refer to Chang et al. (2013, 2016) for more discussions on the advantages of the studenized
statistics in marginal screening problems. If |Ŝ1| < p, we put d = p − |Ŝ1| and let µ˜1 ∈ Rd
be the sub-vector of µ1 ∈ Rp containing only the coordinates excluded by Ŝ1. We have
therefore downsized the original problem and instead, we focus on the reduced null hypothesis
H˜ (I)0 : µ˜1 = 0 against the alternative H˜
(I)
1 : µ˜1 6= 0. Write T̂ (I)ns = maxk/∈Ŝ1
√
n|X¯k| and
T̂
(I)
s = maxk/∈Ŝ1
√
n|X¯k|/σˆ1k. The resulting non-studentized and studentized tests are given
by Ψf,(I)ns,α = I{T̂ (I)ns > cv(I)ns,α(Ŝ1)} and Ψf,(I)s,α = I{T̂ (I)s > cv(I)s,α(Ŝ1)}, where cv(I)ns,α(Ŝ1) and
cv(I)s,α(Ŝ1) denote the conditional (1−α)-quantile of maxk/∈Ŝ1 |W
(I)
ns,k| and maxk/∈Ŝ1 |W
(I)
s,k| given
Xn, respectively, with W(I)ns = (W (I)ns,1, . . . ,W (I)ns,p)T and W(I)s = (W (I)s,1, . . . ,W (I)s,p)T as discussed
in Section 2.1.1. Whenever |Ŝ1| = p, we set Ψf,(I)ns,α = Ψf,(I)s,α = 0.
Notice that P
H
(I)
0
{Ψf,(I)ν,α = 1} 6 PH(I)0 [Ψ
f,(I)
ν,α = 1, Ŝ1 = {1, . . . , p}] + PH(I)0 [Ŝ1 6= {1, . . . , p}]
for ν ∈ {ns, s}. Since Ψf,(I)ν,α = 0 if |Ŝ| = p, then PH(I)0 {Ψ
f,(I)
ν,α = 1} 6 PH(I)0 [Ŝ1 6= {1, . . . , p}].
As shown in part D of supplementary material, lim supn→∞ PH(I)0 [Ŝ1 6= {1, . . . , p}] 6 α,
which indicates that the size of the two-step procedure can be controlled by the prescribed
significant level α. On the other hand, also stated in part D of supplementary material,
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P
H
(I)
1
{T̂ (I)ν = T (I)ν } → 1 for ν ∈ {ns, s} which means the testing statistics with screening and
without screening are almost identical under H
(I)
1 . Since the critical value cv
(I)
ν,α(Ŝ1) for two-
step procedure is not larger than cv
(I)
ν,α for non-screening procedure, we know with probability
approaching to one that the power for two-step procedure does not decrease in comparison
to the procedure without screening. The simulation studies in Section 4 also verify this.
2.3.2 Two-sample case. Similar to the one-sample case, for each k = 1, . . . , p, we define
TS(II)k =
√
nm|X¯k − Y¯k|/
(
mσˆ21k + nσˆ
2
2k
)1/2
and set Ŝ2 = {1 6 k 6 p : TS(II)k 6 [
√
2 log(p) +
{2 log(p)}−1/2 +√2 log(1/α)}. If |Ŝ2| < p, the resulting tests, denoted by Ψf,(II)ns,α and Ψf,(II)s,α ,
are defined in the same way as Ψf,(I)ns,α and Ψ
f,(I)
s,α for one-sample case respectively. If |Ŝ2| = p,
we set Ψf,(II)ns,α = Ψ
f,(II)
s,α = 0.
3. Theoretical properties
In this section, we study the properties of the proposed tests including the asymptotic sizes
and powers. In practice, takingM in thousands using numerical devices to increase simulation
efficiency is now the rule rather than the exception in the Monte Carlo framework. The
difference between such large values of M and using mathematically ideal value M = ∞
is particularly small. We therefore focus on the oracle tests Ψ(I)ν,α and Ψ
(II)
ν,α for ν ∈ {ns, s},
and their screening-based analogues Ψf,(I)ν,α and Ψ
f,(II)
ν,α . It is shown that the proposed tests
maintain the nominal size asymptotically under very general covariance structures. Moreover,
the proposed tests are shown to be consistent against sparse alternatives. Recall Σ1 =
(σ1,k`)16k,`6p, Σ2 = (σ2,k`)16k,`6p, D1 = diag (Σ1) and D2 = diag (Σ2). The marginally
standardized version of X and Y are U = (U1, . . . , Up)
T = D
−1/2
1 X and V = (V1, . . . , Vp)
T =
D
−1/2
2 Y, respectively. We only impose the following mild moment conditions.
(M1) max16k6p max[{E(|Uk|r)}1/r, {E(|Vk|r)}1/r] 6 K0 for some r > 4 and K0 > 0
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(M2) max16k6p max[E{exp(K1|Uk|γ)},E{exp(K1|Vk|γ)}] 6 K2 for some K1 > 0, K2 > 1
and 0 < γ 6 2.
Condition (M1) indicates that the tail probability P(|Uk| > t) decays to zero in a faster
rate than t−r as t → ∞. Condition (M2) requires exponentially light tails, i.e., P(|Uk| >
t) 6 exp(−K˜1tγ) for some K˜1 > 0 and all sufficiently large t, and implies that all moments
of Uk are finite. Throughout this section, we assume that σ1,11, . . . , σ1,pp, σ2,11, . . . , σ2,pp are
uniformly bounded away from 0 and ∞, n, p > 2, n  m and n 6 m.
Theorem 1: Let Σ˜1 = Σ̂1, the sample covariance matrix, and ν ∈ {ns, s}. As n, p→∞,
P
H
(I)
0
{Ψ(I)ν,α = 1} → α holds with either (i) (M1) holds and p = O(nr/2−1−δ) for some δ > 0;
or (ii) (M2) holds for some γ > 1/2 and log(p) = o(n1/7).
Theorem 1 establishes the validity of the proposed one-sample tests in the sense that
the testing procedures in Section 2.1.1 maintain nominal significance level asymptotically.
In addition, as evidenced by the numerical experiments in Section 4, the test based on
non-studentized statistics outperforms its studentized analogue in terms of maintaining the
nominal significance level when the sample size is small. This, however, is not surprising
since the inverse operation, say D̂
−1/2
1 , usually leads to an augmentation of the estimation
error in D̂1 and therefore is more sensitive to the sample size. In the following theorem, we
summarize the asymptotic power of the proposed one-sample tests under suitable conditions
on the lower bound of the signal-to-noise ratios.
Theorem 2: Let Σ˜1 = Σ̂1 be the sample covariance matrix. Assume that either condi-
tion (M1) holds and p = O(nr/2−1−δ) for some δ > 0, or condition (M2) holds and log(p) =
o(nγ/2). For given 0 < α < 1, write λ(p, α) =
√
2 log(p) +
√
2 log(1/α), and let {εn}n>1 be
an arbitrary sequence of positive numbers satisfying εn → 0 and εn
√
log(p)→∞ as n→∞.
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As n, p → ∞, we have (i) P
H
(I)
1
{Ψ(I)ns,α = 1} → 1 if max16k6p |µ1k|/max16k6p σ1k > (1 +
εn)n
−1/2λ(p, α), and (ii) P
H
(I)
1
{Ψ(I)s,α = 1} → 1 if max16k6p |µ1k|/σ1k > (1 + εn)n−1/2λ(p, α).
Theorem 2 reveals that the test based on studentized statistics is consistent in a larger
testable region in comparison to the test based on non-studentized statistics. As a comple-
ment to Theorem 1, the asymptotic size of the proposed two-sample tests without screening
is reported below.
Theorem 3: Let (Σ˜1, Σ˜2) = (Σ̂1, Σ̂2) and ν ∈ {ns, s}. Assume that either condition (i)
or condition (ii) in Theorem 1 holds. Then as n, p→∞, P
H
(II)
0
{Ψ(II)ν,α = 1} → α.
Theorem 3 implies that, under proper moment conditions, the proposed two-sample non-
screening tests maintain nominal size α asymptotically, while allowing for either a polynomial
or an exponential rate of growth of the dimension p with respect to the sample size n. In
Theorem 4 below, the asymptotic power of the two-sample non-screening tests is analyzed.
Theorem 4: Let (Σ˜1, Σ˜2) = (Σ̂1, Σ̂2). Assume that either condition (M1) holds and
p = O(nr/2−1−δ) for some δ > 0, or condition (M2) holds and log(p) = o(nγ/2). For given 0 <
α < 1, let λ(p, α) and {εn}n>1 be as in Theorem 2. As n, p→∞, we have (i) PH(II)1 {Ψ
(II)
ns,α =
1} → 1 if max16k6p |µ1k − µ2k|/max16k6p(σ21k/n+ σ22k/m)1/2 > (1 + εn)λ(p, α), and (ii)
P
H
(II)
1
{Ψ(II)s,α = 1} → 1 if max16k6p |µ1k − µ2k|/(σ21k/n+ σ22k/m)1/2 > (1 + εn)λ(p, α).
The following theorem establishes asymptotic properties of the proposed two-step testing
procedures. Part (i) in Theorem 5 below shows that the type I error of the proposed
screening-based two-step procedures can be controlled by the prescribed significance level
asymptotically. Similar to the comparison between the studentized and non-studentized tests
in Theorem 2, parts (ii) and (iii) in Theorem 5 below also imply that the screening-based
two-step studentized test is consistent in a larger region than its non-studentized counterpart.
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Theorem 5: Let Σ˜1 = Σ̂1. Assume that either condition (M1) holds and p = O(n
r/2−1−δ)
for some δ > 0, or condition (M2) holds for some γ > 1
2
and log(p) = o(n1/7). We have (i)
lim supn→∞ PH(I)0 {Ψ
f,(I)
ν,α = 1} 6 α for ν ∈ {ns, s}, (ii) PH(I)1 {Ψ
f,(I)
ns,α = 1} → 1 if the condition
for part (i) in Theorem 2 holds, (iii) P
H
(I)
1
{Ψf,(I)s,α = 1} → 1 if the condition for part (ii) in
Theorem 2 holds.
Similarly, the following theorem establishes the limiting null property and the asymptotic
power for the proposed two-step procedures with pre-screening in the two-sample settings.
Theorem 6: Let (Σ˜1, Σ˜2) = (Σ̂1, Σ̂2). Assume that either condition (M1) holds and p =
O(nr/2−1−δ) for some δ > 0, or condition (M2) holds for some γ > 1
2
and log(p) = o(n1/7).
We have (i) lim supn→∞ PH(II)0 {Ψ
f,(II)
ν,α = 1} 6 α for ν ∈ {ns, s}, (ii) PH(II)1 {Ψ
f,(II)
ns,α = 1} → 1 if
the condition for part (i) in Theorem 4 holds, and (iii) P
H
(II)
1
{Ψf,(II)s,α = 1} → 1 if the condition
for part (ii) in Theorem 4 holds.
4. Simulation studies
In this section, we report the simulation results from several experiments to evaluate the
performance of the proposed tests, including the non-studentized test without screening
Ψns,α, the studentized test without screening Ψs,α, the non-studentized test with screening
Ψfns,α and the studentized test with screening Ψ
f
s,α, for both one- and two-sample problems.
For ease of exposition, we suppress the superscripts (I) and (II). To demonstrate the proposed
tests, we also implemented peer testing procedures for comparison. For the one-sample
problem, we compared the proposed tests with the test by Zhong et al. (2013) (denoted
by ZCX hereafter) and the Higher Criticism (HC) procedure by Donoho and Jin (2004) . We
used the method proposed by Li and Siegmund (2015) to obtain more accurate approximation
of the critical values in HC procedure. For the two-sample problem, we experimented the
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tests by Chen and Qin (2010) (denoted by CQ hereafter) and Cai et al. (2014) (denoted by
CLX hereafter) as well as the HC procedure. .
In the simulation studies, we considered a wide range of covariance structures, including
both the sparse and dense settings to investigate the numerical performance of the proposed
tests. We generate data with sample sizes n = 40 or 80 in one-sample case and (n,m) =
(40, 40) or (80, 80) in two-sample case. The dimension p took values in 120, 360 or 1080.
The empirical size and power were defined as the proportion of the rejection among 1500
replications. We used the sample covariance matrices to generate M = 1500 Monte Carlo
samples to compute the critical values for our proposed tests. We only report the results for
six models in this section and more models are considered in the supplementary material.
4.1 One-sample case
We took µ1 = 0 under the null hypothesis, whereas, under the alternative, we took µ1 =
(µ11, . . . , µ1p)
T to have bκprc non-zero entries uniformly and randomly drawn from {1, . . . , p},
where κ was an integer and bxc denotes the integer part of x. We took r = 0, 0.4, 0.5, 0.7
and 0.85, where κ = 8 if r = 0 and κ = 1 otherwise. The choices of r = 0 and r = 0.7 or 0.85
correspond to the sparse and non-sparse settings, respectively. The magnitudes of non-zero
entries µ1` were set to be {2βσ1,`` log(p)/n}1/2, where σ1,`` denotes the `th diagonal entry of
Σ1. We took β = 0.01, 0.2, 0.4, 0.6 and use β = 0.01 to mimic the scenario of weak signals.
The following two models were used to generate random samples Xi = Zi + µ1 for i =
1, . . . , n, where {Zi}ni=1 i.i.d∼ N(0,Σ1) with Σ1 = (σ1,k`)16k,`6p.
• Model 1(I): σ1,k` = 0.4|k−`| for 1 6 k, ` 6 p.
• Model 2(I): Let {θk}pk=1 i.i.d.∼ Unif(1, 2). We took σ1,kk = θk and σ1,k` = ρα(|k− `|) for k 6= `,
where ρα(e) =
1
2
{(e+ 1)2H + (e− 1)2H − 2e2H} with H = 0.9.
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Model 1(I) has sparse covariance structure while Model 2(I) takes long range dependence
into account which exhibits a non-sparse structure. In addition, we considered the following
model with non-Gaussian data to study the robustness of the proposed tests against Gaussian
assumptions. The covariance structure in the following Model 3(I) is non-sparse.
• Model 3(I): Let {Xi}ni=1 i.i.d.∼ tω(µ1,Σ1), where tω(µ1,Σ1) is the non-central multivariate
t-distribution with non-central parameter µ1, degrees of freedom ω = 5, and σ1,k` =
0.995|k−`|.
Simulation results for the tests Ψns,α, Ψs,α, Ψ
f
ns,α and Ψ
f
s,α and the ZCX and HC tests are
summarized in Table 1 and Figure 1. Table 1 displays the empirical sizes of all the tests.
It can be seen that in all the models, the empirical sizes of the non-studentized tests Ψns,α
and Ψfns,α are reasonably close to the nominal level 0.05 for both n = 40 and n = 80. The
proposed studentized tests Ψs,α and Ψ
f
s,α have slightly inflated size when n is relatively small
but improve with larger sample sizes. The ZCX test maintains the nominal size for Model
1(I) but fails in the presence of long range dependence or non-sparse covariance structures.
The HC procedure also fails in maintaining the nominal significance when the sample size n
is small or the dependency is strong and complex.
[Table 1 about here.]
To compare the empirical powers, we took n = 80 and p = 1080. For Model 1(I), we
compared the proposed tests with the ZCX test (column (a) in Figure 1), whereas, for the
other two models, we only focused on comparing the four proposed tests as they maintain the
nominal size reasonably well and other tests fail in size control. Column (a) in Figure 1 shows
that Ψs,α, Ψ
f
s,α and Ψ
f
ns,α provide non-trivial powers against alternatives with sparse signals
(r = 0) even under the weak signal settings (β = 0.01); in contrast, the ZCX test improves its
power as the signal getting dense, which is expected for sum of squares-type statistics. As the
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signal strength increases, all tests under consideration gain powers. The proposed tests with
screening, Ψfns,α and Ψ
f
s,α, outperform the ZXC test under sparse alternatives (r = 0, 0.4),
and their powers are close to that of the ZCX test for dense signals (r > 0.7). From columns
(b) and (c) in Figures 1, we observe that the screening procedure substantially improves
the power performance of the tests for all settings, which reflects the heuristic discussions
and motivations in Section 2.3.1. The non-studentized test with screening Ψfns,α performs
comparably to, or better than, the studentized test without screening Ψs,α under sparse
alternatives (r 6 0.5). This suggests that Ψfns,α is more preferable in practice given its
capability in maintaining the nominal significance for small sample size.
[Figure 1 about here.]
4.2 Two-sample case
We took µ1 = µ2 = 0 under the null hypothesis, whereas, under the alternative, we let
µ1 = (µ11, . . . , µ1p)
T to have bκprc non-zero entries uniformly and randomly drawn from
{1, . . . , p}, where κ is an integer. As before, we considered r = 0, 0.4, 0.5, 0.7 and 0.85, where
κ = 8 if r = 0 and κ = 1 otherwise. The magnitudes of non-zero entries µ1` were set to be
{2βσ`` log(p)(1/n + 1/m)}1/2, where σ`` is the `th diagonal entry of the pooled covariance
matrix Σ1,2 as in (2.3). We took β = 0.01, 0.2, 0.4, 0.6.
The following two models were used to generate random samples Xi = Z1,i + µ1,Yj =
Z2,j + µ2 for i = 1, . . . , n and j = 1, . . . ,m, where {Z1,i}ni=1 i.i.d.∼ N(0,Σ1) and {Z2,j}mj=1 i.i.d.∼
N(0,Σ2) with Σ1 = (σ1,k`)16k,`6p and Σ2 = (σ2,k`)16k,`6p, respectively.
• Model 1(II): For k = 1, . . . , p and q = 1, 2, σq,kk i.i.d.∼ Unif(2, 3), σq,k` = 0.7 for 10(t−1)+1 6
k 6= ` 6 10t, where t = 1, . . . , bp/10c, and σq,k` = 0 otherwise.
• Model 2(II): Let F = (fk`)16k,`6p with fkk = 1, fk,k+1 = fk+1,k = 0.5, Uq ∼ U(Vp,k0), the
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uniform distribution on the Stiefel manifold for q = 1, 2, and Θ = diag{θ11, . . . , θpp} with
θkk
i.i.d.∼ Unif(1, 6). Set k0 = 10 and put Σq = Θ1/2(F + UqUTq )Θ1/2 for q = 1, 2.
Model 1(II) and Model 2(II) are with sparse and non-sparse covariance structures, respec-
tively. In addition, we considered the following model with non-Gaussian data.
• Model 3(II): Let {Xi}ni=1 i.i.d.∼ tω1(µ1,Σ1) and {Yj}mj=1 i.i.d.∼ tω2(µ2,Σ2), where ω1 = 5, ω2 = 7,
σ1,k` = 0.995
|k−`| and σ2,k` = 0.7|k−`|.
The numerical results on the proposed tests Ψns,α, Ψs,α, Ψ
f
ns,α and Ψ
f
s,α and the HC, CQ
and CLX tests are summarized in Table 2 and Figure 2. Table 2 displays the empirical sizes.
It can be seen that in all the models, the empirical sizes for Ψns,α and Ψ
f
ns,α are reasonably
close to the nominal level 0.05 for both (n,m) = (40, 40) and (80, 80). The studentized tests,
Ψs,α and Ψ
f
s,α, have slightly inflated significance when the sample size is relatively small
but improve when the sample size increases. Additionally, the CLX test fails to maintain
the nominal size for Model 3(II) due to the strong dependency in the covariance structures.
Analogous to the observation in Section 4.1, it is difficult for the HC procedure to maintain
the nominal significance when the sample size is small or the dependency is strong and
complex. The CQ test maintains the nominal significance reasonably well in all the models.
[Table 2 about here.]
To evaluate the power, we compared the proposed tests with the CQ and CLX tests for
(n,m) = (80, 80) and p = 1080. It can be seen that the tests with screening, Ψfns,α and Ψ
f
s,α,
outperform both the CQ and CLX tests against alternatives with sparse signals (r = 0)
for different signal strength β. On the other hand, all the tests perform similarly when the
signals become less sparse and strong. The CQ test gains more powers when signals become
less sparse, as expected for sum of squares-type statistics. Its power approaches to those of
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the proposed tests with screening Ψfns,α and Ψ
f
s,α when the signals become less sparse and
stronger (r > 0.5, β > 0.4) in the models except Model 3(II). In Model 3(II), all the proposed
tests outperform the CQ test substantially as the sum of squares-type test statistics may
lose power for heavy tailed sampling distributions. The CLX test performs similarly to the
Ψns,α and Ψs,α, but is outperformed by the proposed tests with screening for all settings. The
simulation results agree with the heuristic discussion and the theoretical justification that the
screening step substantially improves the power of proposed tests. Similar to the observations
in Section 4.1, Ψfns,α is preferable in practice whenever the sample size is relatively small.
[Figure 2 about here.]
In summary, the numerical results show that the proposed tests, particularly the studen-
tized tests and the non-studentized test with screening, Ψs,α, Ψ
f
s,α and Ψ
f
ns,α, outperform the
existing methods when the covariance structure is non-sparse and complex. The proposed
tests are robust against both unknown covariance structures and Gaussianity. The Ψfns,α
maintains the nominal significance for small sample sizes and has good powers against sparse
alternatives, which is recommended for practical applications with relatively small sample
size. The Ψfs,α is more powerful and thus is preferable in applications with relatively large
samples, such as biomedical research with a large cohort.
More extensive simulations were carried out for dimensions p = 120 and 360, from which
the comparisons are consistent with the cases that are reported here. The empirical powers
of all the tests also increase in p. All the additional simulation results are placed in the online
supplementary materials. Furthermore, extra simulations were reported in the supplementary
materials to demonstrate that the proposed procedures may benefit from using regularized
covariance estimations when the covariance matrices do admit special structures.
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5. Empirical study
Analysis and interpretation based on gene-sets or GO terms derive more power than focusing
on individual gene in extracting biological insights (Subramanian et al., 2005). It has drawn
increasing attentions to identify GO terms associated with biological states of interest (Sub-
ramanian et al., 2005; Efron and Tibshirani, 2007; Recknor et al., 2008). A particular GO
term belongs to one of the three categories of gene ontologies of interest: biological processes
(BP), cellular components (CC) and molecular functions (MF).
Statistically, identifying interesting gene-sets out of G candidate gene-sets S1, . . . ,SG based
on independent samples from two biological states (q = 1, 2) is equivalent to test hypotheses
H0s : µ1,s = µ2,s versus H1s : µ1,s 6= µ2,s for s = 1, . . . , G, where µq,s models the mean
expression levels of ps genes in the gene-set Ss under biological state q. It is common that
gene-sets overlap with each other as one particular gene may belong to several functional
groups, and the size of a gene-set ps usually range from a small to a very large number.
The selection of gene-sets therefore encounters both multiplicity and high dimensionality.
Similar to Chen and Qin (2010), we applied the proposed tests to each gene-set. With p-
values obtained for all G gene-sets, we further employed the multiple testing methods such
as the Benjamini-Yekutieli (BY) procedure (Benjamini and Yekutieli, 2001) for controlling
the false discovery rate (FDR) under dependeny to identify significant gene-sets.
We applied the above procedure to a human acute lymphoblastic leukemia (ALL) dataset
which is available at http://www.ncbi.nlm.nih.gov. The data contains gene expression
levels from microarray experiments for patients suffering from ALL of either T-lymphocyte
type or B-lymphocyte type leukemia. This dataset was originally analyzed by Chiaretti et
al. (2004) to provide insight into the genetic mechanism on ALL development and it was also
analyzed by Dudoit et al. (2011) and Chen and Qin (2010) using different methodologies.
To illustrate the proposed tests, we focus on the 75 patients of B-lymphocyte type leukemia,
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who were classified into two groups: 35 patients with BCR/ABL fusion and 40 patients
with cytogenetically normal NEG, i.e., n = 35 and m = 40. We employed the approach in
Gentleman et al. (2005) to conduct preliminary data processing. To focus on high dimensional
scenarios, we also excluded gene-sets with ps 6 19. It remained G = 1853, 262 and 284
unique GO terms in the BP, CC and MF categories, respectively. And the largest gene-set
contained ps = 3050, 3145 and 3040 genes in the BP, CC and MF categories, respectively.
Given the complexity of the data processing and collection procedures, batch effects may
exist and result in unreliable results. Therefore, we further employ the surrogate variable
analysis (SVA) method proposed by Leek and Storey (2007) to remove the potential batch
effects and other unwanted variations in the data. In summary, two surrogate variables
were found by SVA and removed from the original ALL expression data. Identifications of
gene-sets associated to the BCR/ABL fusion display biological insights on the development
of B-lymphocyte type leukemia and provide lists of functional groups for potential clinical
treatments. We aim to identify gene-sets with significantly different expression levels between
the BCR/ABL and NEG groups for each of the three categories.
The sample size of the ALL data is relatively small comparing to the maximum ps, we
therefore employed the proposed two-sample non-studentized tests Ψns,α and Ψ
f
ns,α in the
analysis as suggested by simulation studies in Section 4. Based on empirical p-values, we
further employed the BY procedure for controlling the FDR at 0.015 and identify significant
gene-sets. For the proposed tests, we let M = 50000 and used the sample covariance matrices
to generate samples. Simulation studies in Section 4 have shown that the test by Cai et al.
(2014) may inflate type I error rate for small sample size, we therefore only consider the test
by Chen and Qin (2010) (CQ) as a reference. For each category, the numbers of gene-sets
being identified are summarized in Table 3. All the gene-sets identified by the proposed two-
step test Ψfns,α are also identified by CQ methods. This suggests that CQ test may over-detect
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some disease-associated gene-sets. Moreover, Ψfns,α found more disease associated gene-sets
than Ψns,α, which reflects the power improvement of the proposed two-step testing procedure
as discussed before.
[Table 3 about here.]
By carefully investigating the gene-sets identified by both the proposed tests Ψns,α and
Ψfns,α, we found that gene-sets GO:0005758 (mitochondrial intermembrane space) and GO:0004860
(protein kinase inhibitor activity) were identified as diseases-associated in the CC and
MF categories. The functions of these two interesting gene-sets were recently studied and
recognized associated with the development of ALL (Brinkmann and Kashkar, 2014; Cui et
al., 2009). Particularly, the protein kinase inhibition has been considered to be essential for
the mechanism of T-lymphocyte type ALL (Cui et al., 2009) and our finding suggests its
connection with B-lymphocyte type ALL as well. The association of these gene-sets with the
ALL may deserve further biological validations using the polymerase chain reaction.
6. Supplementary Materials
Web Appendices, which include proofs of the main theorems and additional numerical results
referenced in Section 3 and 4 are available with this paper at the Biometrics website on Wiley
Online Library.
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(a) Model 1(I) (b) Model 2(I) (c) Model 3(I)
Figure 1. Empirical powers of the proposed tests (non-studentized without screening
Ψns,α, studentized without screening Ψs,α, non-studentized with screening Ψ
f
ns,α, and also
studenzied with screening Ψfs,α) against alternatives with different levels of the signal strength
(β) and sparsity (1 − r) for the one-sample problem (1.1) when n = 80 and p = 1080 at
5% nominal significance for the Gaussian data and sparse covariance matrices in Model 1(I)
(column (a)), the Gaussian data and long range dependence covariance matrices in Model 2(I)
(column (b)), and the autoregressive process model, Model 3(I), with t-distributed innovations
(column (c)). Column (a) also displays the powers of the test by Zhong et al. (2013) (ZCX).
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(a) Model 1(II) (b) Model 2(II) (c) Model 3(II)
Figure 2. Empirical powers of the proposed tests (non-studentized without screening
Ψns,α, studentized without screening Ψs,α, non-studentized with screening Ψ
f
ns,α, and also
studenzied with screening Ψfs,α) against alternatives with different levels of the signal strength
(β) and sparsity (1 − r) for the two-sample problem (1.2) when n = 80 and p = 1080 at
5% nominal significance for the Gaussian data and sparse covariance matrices in Model 1(II)
(column (a)), the Gaussian data and non-sparse covariance matrices in Model 2(II) (column
(b)), and the non-Gaussian data in Model 3(II) (column (c)). The powers of the tests by
Chen and Qin (2010) (CQ) and Cai et al. (2014) (CLX) are also displayed.
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Model 1(I) Model 2(I) Model 3(I)
tests / p 120 360 1080 120 360 1080 120 360 1080
n = 40
Ψns,α 0.037 0.027 0.021 0.025 0.028 0.023 0.054 0.044 0.033
Ψs,α 0.133 0.126 0.168 0.093 0.113 0.202 0.065 0.080 0.096
Ψfns,α 0.044 0.045 0.043 0.039 0.027 0.039 0.054 0.046 0.033
Ψfs,α 0.150 0.154 0.194 0.095 0.170 0.218 0.060 0.058 0.093
ZCX 0.064 0.078 0.089 1 1 1 0.382 0.487 0.673
HC 0.123 0.225 0.316 0.129 0.249 0.320 0.274 0.377 0.468
n = 80
Ψns,α 0.037 0.036 0.029 0.040 0.032 0.042 0.049 0.047 0.040
Ψs,α 0.060 0.082 0.092 0.082 0.083 0.094 0.058 0.058 0.067
Ψfns,α 0.048 0.045 0.043 0.051 0.045 0.040 0.049 0.048 0.044
Ψfs,α 0.086 0.097 0.094 0.095 0.091 0.110 0.060 0.058 0.069
ZCX 0.080 0.072 0.071 1 1 1 0.404 0.506 0.702
HC 0.063 0.119 0.142 0.079 0.145 0.175 0.267 0.363 0.471
Table 1
Empirical sizes of the proposed tests (non-studentized without screening Ψns,α, studentized without screening Ψs,α,
non-studentized with screening Ψfns,α, and studenzied with screening Ψ
f
s,α) for the one-sample problem (1.1), along
with those of the tests by Zhong et al. (2013) (ZCX), and Donoho and Jin (2004) (HC) at 5% nominal significance.
Models with Gaussian data and sparse or long range dependence (non sparse) covariance matrices, and the
autoregressive model with t-distributed innovations are considered when n = 40, 80 and p = 120, 360, 1080.
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Model 1(II) Model 2(II) Model 3(II)
tests / p 120 360 1080 120 360 1080 120 360 1080
midrule (n,m) = (40, 40)
Ψns,α 0.039 0.041 0.041 0.042 0.044 0.039 0.052 0.036 0.042
Ψs,α 0.094 0.112 0.125 0.092 0.097 0.116 0.086 0.090 0.092
Ψfns,α 0.055 0.048 0.057 0.049 0.055 0.054 0.055 0.039 0.052
Ψfs,α 0.092 0.120 0.152 0.098 0.131 0.053 0.090 0.094 0.094
HC 0.086 0.156 0.157 0.078 0.144 0.148 0.172 0.237 0.283
CQ 0.044 0.049 0.034 0.046 0.049 0.051 0.064 0.066 0.054
CLX 0.101 0.103 0.138 0.081 0.087 0.098 0.204 0.181 0.137
(n,m) = (80, 80)
Ψns,α 0.054 0.039 0.046 0.053 0.040 0.040 0.046 0.045 0.047
Ψs,α 0.074 0.062 0.086 0.058 0.064 0.090 0.059 0.065 0.074
Ψfns,α 0.065 0.052 0.060 0.063 0.050 0.058 0.047 0.048 0.056
Ψfs,α 0.088 0.076 0.098 0.070 0.080 0.093 0.062 0.069 0.086
HC 0.068 0.086 0.099 0.053 0.085 0.085 0.165 0.239 0.263
CQ 0.046 0.039 0.048 0.048 0.038 0.048 0.044 0.054 0.056
CLX 0.107 0.090 0.104 0.057 0.057 0.089 0.289 0.352 0.297
Table 2
Empirical sizes of the proposed tests (non-studentized without screening Ψns,α, studentized without screening Ψs,α,
non-studentized with screening Ψfns,α, and studenzied with screening Ψ
f
s,α) for the two-sample problem (1.2), along
with those of the tests by Donoho and Jin (2004) (HC), Chen and Qin (2010) (CQ), and Cai et al. (2014) (CLX)
at 5% nominal significance. Models with Gaussian data and sparse or non-sparse covariance matrices, and with
non-Gaussian data are considered when n = m = 40 or 80 and p = 120, 360, 1080.
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GO
Ψns,α
Ψfns,α and CQ Total maxs ps mins ps bp¯sc
Category Ψfns,α only Both CQ only
BP 601 0 956 560 1853 3050 20 150
CC 52 0 99 17 262 3145 19 280
MF 95 0 150 77 284 3040 19 157
Table 3
Numbers of identified BCR/ABL associated gene-sets for each GO category using different tests in conjunction with
the BY procedure by Benjamini and Yekutieli (2001) for controlling FDR at 0.015. Columns labeled by the name of
tests records the number of identified gene-sets by the corresponding testing procedures, where Ψns,α and Ψ
f
ns,α are
the proposed non-studentized tests without and with screening, and CQ stands for the test by Chen and Qin (2010).
